A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague (Q57459044)

National Institute of Allergy and Infectious Diseases

4

affiliation

object named as

Mahtab Moayeri

0 references

author name string

Pan Tao

The Catholic University of America

1

affiliation

0 references

Marthandan Mahalingam

2

0 references

Jingen Zhu

3

0 references

Jian Sha

5

0 references

William S Lawrence

6

0 references

Ashok K Chopra

8

0 references

Venigalla B Rao

American Society for Microbiology

9

0 references

publisher

0 references

https://www.sciencedaily.com/releases/2018/10/181016081351.htm

0 references

publication date

16 October 2018

0 references

number of pages

13

0 references

distribution format

digital distribution

0 references

described at URL

https://www.precisionvaccinations.com/t4-nanoparticle-novel-platform-developing-multivalent-vaccines-against-pathogens-high-public-health

0 references

full work available at URL

0 references

https://mbio.asm.org/content/mbio/9/5/e01926-18.full.pdf

American Society for Microbiology

content deliverer

0 references

published in

mBio

0 references

volume

9

0 references

issue

5

0 references

cites work

A new improved sub-unit vaccine for plague: the basis of protection

1 reference

12 December 2020

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

1 reference

12 December 2020

The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.

1 reference

12 December 2020

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

12 December 2020

Anthrax as a biological weapon, 2002: updated recommendations for management

1 reference

12 December 2020

Development of an improved vaccine for anthrax

1 reference

12 December 2020

Molecular architecture of the prolate head of bacteriophage T4.

1 reference

12 December 2020

Crystal structure of a complex between anthrax toxin and its host cell receptor

1 reference

12 December 2020

Cell-mediated protection against pulmonary Yersinia pestis infection

1 reference

12 December 2020

Assembly of the small outer capsid protein, Soc, on bacteriophage T4: a novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid.

1 reference

12 December 2020

Current challenges in the development of vaccines for pneumonic plague

1 reference

12 December 2020

Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92.

1 reference

12 December 2020

Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice

1 reference

12 December 2020

Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding

1 reference

12 December 2020

Structure of the Small Outer Capsid Protein, Soc: A Clamp for Stabilizing Capsids of T4-like Phages

1 reference

12 December 2020

Acceptable levels of endotoxin in vaccine formulations during preclinical research

1 reference

12 December 2020

Pathology of inhalational anthrax animal models

1 reference

12 December 2020

Virus-like particles in vaccine development.

1 reference

12 December 2020

Vaccine Adjuvants: Putting Innate Immunity to Work

1 reference

12 December 2020

Highly effective generic adjuvant systems for orphan or poverty-related vaccines

1 reference

12 December 2020

Progress on plague vaccine development

1 reference

12 December 2020

Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores

1 reference

12 December 2020

Beyond empiricism: informing vaccine development through innate immunity research

1 reference

12 December 2020

Filamentous bacteriophage fd as an antigen delivery system in vaccination

1 reference

12 December 2020

Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

1 reference

12 December 2020

A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague

1 reference

12 December 2020

Rapid deamidation of recombinant protective antigen when adsorbed on aluminum hydroxide gel correlates with reduced potency of vaccine

1 reference

12 December 2020

In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine

1 reference

12 December 2020

Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed

1 reference

12 December 2020

Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines

1 reference

12 December 2020

Anthrax vaccines: present status and future prospects.

1 reference

12 December 2020

Rational considerations about development of live attenuated Yersinia pestis vaccines

1 reference

12 December 2020

Vaccines, new opportunities for a new society

1 reference

12 December 2020

Phage lambda capsids as tunable display nanoparticles

1 reference

12 December 2020

Raising expectations for subunit vaccine

1 reference

12 December 2020

Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles

1 reference

12 December 2020

Formulation and stabilization of recombinant protein based virus-like particle vaccines

1 reference

12 December 2020

Anthrax prophylaxis: recent advances and future directions

1 reference

12 December 2020

Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine

1 reference

12 December 2020

Highly Effective Soluble and Bacteriophage T4 Nanoparticle Plague Vaccines Against Yersinia pestis

1 reference

12 December 2020

Vaccine technologies: From whole organisms to rationally designed protein assemblies

1 reference

12 December 2020

A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

1 reference

12 December 2020

The immune system of the gut and potential adverse effects of oral nanocarriers on its function

1 reference

12 December 2020

Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine

1 reference

12 December 2020

Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.

1 reference

12 December 2020

A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis

1 reference

12 December 2020

Cryo-EM structure of the bacteriophage T4 isometric head at 3.3-Å resolution and its relevance to the assembly of icosahedral viruses

1 reference

12 December 2020

Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.

1 reference

12 December 2020

Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.

1 reference

12 December 2020

Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases

1 reference

12 December 2020